Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/30/2003WO2003051831A3 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
10/30/2003WO2003051388A3 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
10/30/2003WO2003051312A3 E2f and cancer therapy
10/30/2003WO2003051308A3 Antisense modulation of tfap2c expression
10/30/2003WO2003049783A3 Device and methods for harvesting tissue samples of known geometry
10/30/2003WO2003049700B1 Growth hormone releasing hormone suplementation for treating chronically ill subjects
10/30/2003WO2003047421A3 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003WO2003045404A3 Treatment and diagnosis of diseases associated with adverse levels of zinc, cadmium and calcium
10/30/2003WO2003040310A3 Novel epidermal growth factor protein and gene, and methods of use therefor
10/30/2003WO2003039491A8 Novel isoforms of vascular endothelial cell growth inhibitor
10/30/2003WO2003038032A3 Means for inhibition of the synthesis of viral proteins
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003032899A3 Methods and materials for targeting and affecting selected cells
10/30/2003WO2003031588A3 Hepatitis c virus vaccine
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003029482A3 Diagnosing, treating, and preventing cancer using cables
10/30/2003WO2003029428A3 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
10/30/2003WO2003028527A3 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003024419B1 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
10/30/2003WO2003022243A3 Sustained release of microcrystalline peptide suspensions
10/30/2003WO2003020320A3 Nanoparticles comprising biologically active tnf which is immobilised on the same
10/30/2003WO2003018836A3 Model of autoimmune disease and methods for identifying agents against autoimmune disease
10/30/2003WO2003018821A3 Compositions and methods for treating neurodegenerative diseases
10/30/2003WO2003018815A3 Regulation of human g protein-couple receptor kinase
10/30/2003WO2003018619A3 Antimicrobial and anti-inflammatory peptides
10/30/2003WO2003018600A3 Antisense modulation of microsomal triglyceride transfer protein expression
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003014310A3 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
10/30/2003WO2003008628A3 Enzymatic nucleic acid peptide conjugates
10/30/2003WO2003008626A3 Novel human nucleic acids encoding a pantothenate kinase and methods of use
10/30/2003WO2003006668A3 Haptoglobin Derived Antioxidants
10/30/2003WO2003000877A3 A soluble complex comprising a retroviral surface glycoprotein
10/30/2003WO2003000717A3 Identification of ses-3 (spr-5) in c. elegans and the uses of the same
10/30/2003WO2002102229A3 Diagnosing tumorigenicity and determining resistance to anticancer therapy
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002095038A3 Vectors for enhanced expression of vegf for disease treatment
10/30/2003WO2002090526A3 Human secreted proteins
10/30/2003WO2002085941A3 Modified interferon alpha with reduced immunogenicity
10/30/2003WO2002085847A3 Glycine, n-[n-l-gamma-glutamyl-3-(nitrosothio)-l-valyl] and use thereof
10/30/2003WO2002085340A3 Oligonucleotide compositions and their use to induce differentiation of cells
10/30/2003WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/30/2003WO2002083945A3 Diagnosis and treatment of cancer: i
10/30/2003WO2002079247A3 Intimins in the prevention or treatment of infections:ii
10/30/2003WO2002074943A3 Nucleic acid molecules coding for a dextran-saccharase catalysing the synthesis of dextran with alpha 1,2-osidic sidechains
10/30/2003WO2002074803A3 Regulation of human icos v protein
10/30/2003WO2002074788A3 TRP2 ISOFORM TRP2-6b CONTAINING HLA-A2-RESTRICTED EPITOPES
10/30/2003WO2002072106A3 Combined method for treating hormono-dependent disorders with exemestane
10/30/2003WO2002070547A8 Template-fixed peptidomimetics with antimicrobial activity
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002068610A3 Compositions and methods for affecting virulence determinants in bacteria
10/30/2003WO2002064784A3 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter
10/30/2003WO2002062833A3 Modified leptin with reduced immunogenicity
10/30/2003WO2002060474A3 Mixtures of mushroom enzymes and the use thereof for treating maldigestion
10/30/2003WO2002059327A3 Sulfatases and methods of use thereof
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002056916A3 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
10/30/2003WO2002056903A3 Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
10/30/2003WO2002055704A3 Proteins, polynucleotides encoding them and methods of using the same
10/30/2003WO2002054881A3 The use of food and drink as a delevery system for phytase in humans
10/30/2003WO2002050244A3 Antisense modulation of histone deacetylase 1 expression
10/30/2003WO2002050243A3 The use of ecm degrading enzymes for the improvement of cell transplantation
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002032447A3 Cell damage inhibitor
10/30/2003WO2002026826A3 Proteins and nucleic acids encoding same
10/30/2003WO2002026817A3 33521, a human guanine nucleotide exchange family member and uses thereof
10/30/2003WO2002022819A3 Calcium binding proteins
10/30/2003WO2002020716A3 Antisense modulation of phosphorylase kinase alpha 2 expression
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003WO2001085154A8 Method of treating immune pathologies with low dose estrogen
10/30/2003WO2001074136A3 Telomerase inhibitor polynucleotides
10/30/2003WO2001057071A3 Glycopeptide derivatives having antibiotic activity
10/30/2003US20030204868 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
10/30/2003US20030204863 Nav2 channel gene-deficient non-human animals
10/30/2003US20030204097 For inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease
10/30/2003US20030204076 Antisense modulation of vascular endothelial growth factor receptor-1 expression
10/30/2003US20030204073 Identifying an allosteric modulator/antagonist of g-protein coupled receptors for treatment of metabolic disorders
10/30/2003US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases
10/30/2003US20030204071 109 human secreted proteins
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204066 Using to anticytokine to treat rheumatic diseases; immunotherapy; immunoassay
10/30/2003US20030204065 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
10/30/2003US20030204063 Growth hormone releasing factor; somatostatins; glucagon-like peptides; adrenocorticotropic hormones; atriopeptins; vasoactive intestinal peptides; for glucose intolerance associated with insulin resistance
10/30/2003US20030204060 Prepared by fermenting, incubating and eluting by washing with buffer, then chromatographing concentrated medium with lipophilic immobile phase comprising carrier coupled to 2-mercapto/hydroxyalkanoic acid
10/30/2003US20030204059 Preparing cytotoxic lymphocyte maturation factor (CLMF) from genetically engineered lymphoblastoid cells; for treating and preventing tumors and inflammation
10/30/2003US20030204058 Dendritic enriched secreted lymphocyte activation molecule
10/30/2003US20030204057 Chemically modified G-CSF
10/30/2003US20030204055 Comprise nucleotide sequences coding polypeptide for treating and preventing inflammation, tumors and nervous system disorders; animal models; gene therapy
10/30/2003US20030204053 Comprise nucleotide sequences coding polypeptide for treating and preventing inflammation, tumors and nervous system disorders; animal models; gene therapy
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030204051 Contacting a sample with an aggregating amyloid A beta peptide to which is covalently bonded a fluorescent label and detecting the fluorescent label in association with such sample as an indication of an amyloid aggregate
10/30/2003US20030204050 Comprises polypeptide for treating arthritis, cancer, autoimmune, kidney and inflammatory disorders
10/30/2003US20030204049 Which have affinity/targeting vector for integrin receptors; diagnostic imaging
10/30/2003US20030204037 Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks
10/30/2003US20030203976 Anti-angiogenic compositions and methods of use
10/30/2003US20030203975 Such as complex of amino acid/peptide and 1-(2-hydroxyethylamino)anthracene-9,10-dione
10/30/2003US20030203913 Beta3 adrenergic receptor agonists and uses thereof
10/30/2003US20030203903 Administering a rifamycin microbiocides for treating infections caused by Mycobacterium tuberculosis, Mycobacterium avium complex, Chlamydia pneumoniae or Helicobacter pylori
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
1 ... 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 ... 3163